Neuren Pharmaceuticals (NEU) News Today → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free NEU Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineASX loses 1.3% on back of Wall Street decline, gold price hits new high and the world's richest people are getting richer — as it happenedmsn.com - April 3 at 7:45 AMHere's Why Neuren Pharmaceuticals (ASX:NEU) Has Caught The Eye Of Investorsfinance.yahoo.com - April 1 at 11:21 PM20 Biggest Health Care Companies in Australia, 2024uk.finance.yahoo.com - March 26 at 7:25 AMThe best ASX shares to invest $500 in right nowfool.com.au - March 18 at 4:41 PM$10k of savings? I'd buy these ASX 200 shares to grow my moneyfool.com.au - March 11 at 1:33 PMNeuren Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Modelsfinance.yahoo.com - March 3 at 12:25 AMWhat's with the Neuren Pharmaceuticals share price today?fool.com.au - February 29 at 9:09 AMInflation remains at two-year low, Optus sacks extra 200 staff, Sony terminates 8pc of workforce, ASX finishes flat — as it happenedmsn.com - February 28 at 10:00 AMWhy is this ASX 200 pharmaceuticals stock crashing 15% today?fool.com.au - February 28 at 12:09 AMNeuren (NEU) Shares Plunge as Short Seller Targets Partner Acadiamsn.com - February 16 at 9:54 AMThis ASX 200 healthcare share is diving 13% as short sellers take aimfool.com.au - February 15 at 8:41 PMStock Market Outlook In 2024forbes.com - January 18 at 2:30 PMJefferies Keeps Their Buy Rating on Clinuvel Pharmaceuticals Limited (CLVLF)markets.businessinsider.com - January 15 at 3:39 PM3 pharma shares outshining the ASX index todayfool.com.au - January 12 at 1:31 AMThe Neuren Pharmaceuticals share price is up 100% in 3 months: Can it keep rising?fool.com.au - January 8 at 11:25 PMThe No. 1 ASX 200 shares of each market sector in 2023fool.com.au - January 6 at 5:59 PMAnalysts Are Bullish on These Healthcare Stocks: Innovent Biologics (IVBXF), Telix Pharmaceuticals Ltd. (TLPPF)markets.businessinsider.com - January 4 at 7:53 AMAn Intrinsic Calculation For Neuren Pharmaceuticals Limited (ASX:NEU) Suggests It's 44% Undervaluedfinance.yahoo.com - December 26 at 6:32 PMWhy Boss Energy, Lynas, Neuren, and Ora Banda shares are rising todayfool.com.au - December 22 at 1:39 AMNeuren Pharmaceuticals' shares surge on positive Phase 2 clinical trial resultsau.investing.com - December 19 at 1:22 AMGuess which ASX 200 stock was just upgraded and tipped to rise 20%+fool.com.au - December 18 at 8:08 PMWhy is this ASX 200 healthcare stock surging 32% on Monday?fool.com.au - December 17 at 10:50 PMAustralia Shares Rise, Helped by Healthcare Stocksfinance.yahoo.com - December 13 at 1:09 AMNew fund targets companies battered by market doubtsafr.com - December 10 at 8:05 PMNeuren Pharmaceuticals Ltd NEUmorningstar.com - November 6 at 9:11 AMAcadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Upfinance.yahoo.com - November 3 at 2:16 PMBell Potter says these are the best ASX shares to buy in Octoberfool.com.au - October 5 at 7:15 PMAcadia Pharmaceuticals: Difficult Market Masks Progressmsn.com - September 26 at 8:02 AMWilsons downgrades Mayne Pharma Group (MAYNF) to a Sellmarkets.businessinsider.com - September 7 at 3:04 AMBell Potter Keeps Their Buy Rating on Neuren Pharmaceuticals Limited (NURPF)markets.businessinsider.com - August 31 at 11:40 PMIs Weakness In Neuren Pharmaceuticals Limited (ASX:NEU) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?finance.yahoo.com - August 30 at 7:46 PMMove over Neuren – Bioshares reckons these ASX health stocks could pop with upcoming key catalystsmsn.com - August 22 at 8:05 AMAcadia (ACAD) Q2 Earnings & Revenues Beat Estimates, '23 View Upmsn.com - August 3 at 1:13 PMAcadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overviewfinance.yahoo.com - August 2 at 8:21 PMAre Investors Undervaluing Neuren Pharmaceuticals Limited (ASX:NEU) By 23%?finance.yahoo.com - July 19 at 7:04 PMAcadia Pharmaceuticals Rights Deal and Bullish Outlook Sends Shares Surging 16%. Here's What to Expect.247wallst.com - July 17 at 11:55 PMAcadia (ACAD) Soars 24.7%: Is Further Upside Left in the Stock?finance.yahoo.com - July 17 at 8:54 AMAcadia Pharmaceuticals Rights Deal and Bullish Outlook Sends Shares Surging 16%. Here’s What To Expectmsn.com - July 17 at 8:54 AMWhy Are Acadia Pharmaceuticals Shares Trading Higher Today?msn.com - July 14 at 12:42 PMHere’s Why Acadia (NASDAQ:ACAD) Stock Shot Up 23% Yesterdaymsn.com - July 14 at 7:41 AMThese 3 ASX shares are in the buy zone right nowmsn.com - May 30 at 2:05 AMWilsons Reaffirms Their Buy Rating on Immutep Ltd (PRRUF)markets.businessinsider.com - May 22 at 8:27 AM2023 Chronic Brain Damage Treatment Market Size and Insight Report in Pharma & Healthcare Sector | with [105 Pages] and Forecast till 2031marketwatch.com - May 16 at 12:23 AMPositive Report for Mayne Pharma Group (MAYNF) from Wilsonsmarkets.businessinsider.com - May 16 at 12:23 AM2023-2030 Global Traumatic Brain Injury Therapeutics Market is Growing Rapidly with Emerging Patternmarketwatch.com - May 3 at 10:37 AMGlobal "Traumatic Brain Injury Therapeutics Market" Growth and Outlook till 2023-2030marketwatch.com - April 28 at 6:36 PM2023 Phelan-McDermid Syndrome (PMS) Market Size and Growth Analysis with [86 Pages] | Exclusive Report till 2030marketwatch.com - April 19 at 9:27 PMRegeneron Pharmaceuticals Inc REGN Stock Quotemorningstar.com - April 19 at 9:27 PMThree popular stocks on trading platform Stake and why investors are turning to goldmsn.com - April 11 at 2:15 PMAcadia (ACAD) Down 10.9% Since Last Earnings Report: Can It Rebound?finance.yahoo.com - March 29 at 2:07 PM Get Neuren Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NEU and its competitors with MarketBeat's FREE daily newsletter. Email Address Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers. Find out what it is and see how you can get in with just a few dollars. NEU Media Mentions By Week NEU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEU News Sentiment▼0.000.43▲Average Medical News Sentiment NEU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEU Articles This Week▼00▲NEU Articles Average Week Get Neuren Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NEU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Artelo Biosciences News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NEU) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuren Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
